Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
Among middle-aged women taking semaglutide, menopause hormone therapy use was associated with greater weight loss in an observational conference study. Tirzepatide findings were less consistent, and the results have not undergone journal peer review.
Ambulatory Care Nursing November 12th 2026
“People are more used to taking pills than they are taking injections” but “90% of a person’s weight is the result of what they eat. There are no magic solutions.”
Ambulatory Care Nursing January 29th 2026